20-3471261-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_139321.3(ATRN):c.154C>T(p.Leu52=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0128 in 1,448,050 control chromosomes in the GnomAD database, including 1,281 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.055 ( 726 hom., cov: 33)
Exomes 𝑓: 0.0078 ( 555 hom. )
Consequence
ATRN
NM_139321.3 synonymous
NM_139321.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.316
Genes affected
ATRN (HGNC:885): (attractin) This gene encodes both membrane-bound and secreted protein isoforms. A membrane-bound isoform exhibits sequence similarity with the mouse mahogany protein, a receptor involved in controlling obesity. A secreted isoform is involved in the initial immune cell clustering during inflammatory responses that may regulate the chemotactic activity of chemokines. [provided by RefSeq, Apr 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.67).
BP6
Variant 20-3471261-C-T is Benign according to our data. Variant chr20-3471261-C-T is described in ClinVar as [Benign]. Clinvar id is 1167763.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.316 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.18 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ATRN | NM_139321.3 | c.154C>T | p.Leu52= | synonymous_variant | 1/29 | ENST00000262919.10 | |
ATRN | NM_001323332.2 | c.154C>T | p.Leu52= | synonymous_variant | 1/26 | ||
ATRN | NM_139322.4 | c.154C>T | p.Leu52= | synonymous_variant | 1/25 | ||
ATRN | NM_001207047.3 | c.62+127C>T | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ATRN | ENST00000262919.10 | c.154C>T | p.Leu52= | synonymous_variant | 1/29 | 5 | NM_139321.3 | P2 | |
ATRN | ENST00000446916.2 | c.154C>T | p.Leu52= | synonymous_variant | 1/25 | 1 | A2 |
Frequencies
GnomAD3 genomes AF: 0.0550 AC: 8370AN: 152070Hom.: 721 Cov.: 33
GnomAD3 genomes
AF:
AC:
8370
AN:
152070
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0139 AC: 687AN: 49504Hom.: 22 AF XY: 0.0143 AC XY: 413AN XY: 28796
GnomAD3 exomes
AF:
AC:
687
AN:
49504
Hom.:
AF XY:
AC XY:
413
AN XY:
28796
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00777 AC: 10066AN: 1295872Hom.: 555 Cov.: 32 AF XY: 0.00802 AC XY: 5107AN XY: 637104
GnomAD4 exome
AF:
AC:
10066
AN:
1295872
Hom.:
Cov.:
32
AF XY:
AC XY:
5107
AN XY:
637104
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0552 AC: 8404AN: 152178Hom.: 726 Cov.: 33 AF XY: 0.0538 AC XY: 4007AN XY: 74416
GnomAD4 genome
AF:
AC:
8404
AN:
152178
Hom.:
Cov.:
33
AF XY:
AC XY:
4007
AN XY:
74416
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
88
AN:
3460
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 26, 2024 | - - |
ATRN-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jul 30, 2024 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at